RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 129 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,615,000 | -62.2% | 1,429,630 | 0.0% | 0.01% | -55.2% |
Q1 2022 | $4,274,000 | -27.4% | 1,429,630 | -35.7% | 0.03% | -23.7% |
Q4 2021 | $5,887,000 | -27.0% | 2,221,696 | 0.0% | 0.04% | -30.9% |
Q3 2021 | $8,064,000 | -16.4% | 2,221,696 | 0.0% | 0.06% | -16.7% |
Q2 2021 | $9,642,000 | +1334.8% | 2,221,696 | +693.5% | 0.07% | +1000.0% |
Q3 2020 | $672,000 | -81.1% | 280,000 | -85.6% | 0.01% | -84.2% |
Q2 2020 | $3,556,000 | -30.4% | 1,943,000 | -20.5% | 0.04% | -33.3% |
Q1 2020 | $5,111,000 | -2.2% | 2,443,000 | 0.0% | 0.06% | +1.8% |
Q4 2019 | $5,228,000 | +12.8% | 2,443,000 | -1.4% | 0.06% | -8.2% |
Q3 2019 | $4,634,000 | -67.5% | 2,478,000 | -0.3% | 0.06% | -65.7% |
Q2 2019 | $14,275,000 | +124.1% | 2,485,450 | +0.3% | 0.18% | +119.8% |
Q1 2019 | $6,369,000 | +11.8% | 2,478,000 | 0.0% | 0.08% | -8.0% |
Q4 2018 | $5,699,000 | -21.7% | 2,478,000 | +9.3% | 0.09% | -9.3% |
Q3 2018 | $7,280,000 | +63.9% | 2,268,000 | +44.5% | 0.10% | +38.6% |
Q2 2018 | $4,443,000 | -16.6% | 1,570,000 | +4.3% | 0.07% | -23.1% |
Q1 2018 | $5,328,000 | +12.5% | 1,505,000 | +23.4% | 0.09% | +11.0% |
Q4 2017 | $4,734,000 | +47.3% | 1,220,000 | -3.6% | 0.08% | +46.4% |
Q3 2017 | $3,213,000 | -0.3% | 1,265,000 | +7.2% | 0.06% | -8.2% |
Q2 2017 | $3,222,000 | -10.3% | 1,180,000 | +8.8% | 0.06% | -12.9% |
Q1 2017 | $3,592,000 | +145.4% | 1,085,000 | +76.4% | 0.07% | +105.9% |
Q4 2016 | $1,464,000 | -45.0% | 615,000 | -15.2% | 0.03% | -46.9% |
Q3 2016 | $2,661,000 | – | 725,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.02% |